Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Deciphering Metacognition and Treatment Response in Depression With a Novel Digital Paradigm

NCT05464264 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT05464264
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05464264 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Deciphering Metacognition and Treatment Response in Depression With a Novel Digital Paradigm
Lead sponsor
Unity Health Toronto
Phase
Observational
Overall status
Unknown status
Start date
October 3, 2022
Completion date
December 31, 2024
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment-resistant depression (trd)